We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
+12.75%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$104B
AUM Growth
+$8.72B
Cap. Flow
-$256M
Cap. Flow %
-0.25%
Top 10 Hldgs %
26.49%
Holding
4,372
New
62
Increased
2,195
Reduced
1,544
Closed
71

Top Buys

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$35.4M
2
P
Everpure Inc
P
+$21M
3
NVDA icon
NVIDIA
NVDA
+$20.7M
4
AMH icon
American Homes 4 Rent
AMH
+$19.3M
5
DAY
Dayforce
DAY
+$19M

Sector Composition

Rank Sector Weight
1 Technology 28.42%
2 Financials 13.09%
3 Healthcare 11.94%
4 Consumer Discretionary 10.95%
5 Industrials 9.51%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
OPK icon
2326
Opko Health
OPK
$1.04B
$801K ﹤0.01%
667,426
+17,409
+3% +$17.4K
COGT icon
2327
Cogent Biosciences
COGT
$7B
$801K ﹤0.01%
119,133
+3,182
+3% +$19.7K
SBGI icon
2328
Sinclair Inc
SBGI
$1.04B
$800K ﹤0.01%
59,385
+1,175
+2% +$16.8K
IWN icon
2329
iShares Russell 2000 Value ETF
IWN
$14.6B
$799K ﹤0.01%
5,034
+3,299
+190% +$500K
MTW icon
2330
Manitowoc
MTW
$691M
$798K ﹤0.01%
56,426
+1,547
+3% +$22.9K
PNTG icon
2331
Pennant Group
PNTG
$1.37B
$798K ﹤0.01%
40,628
+1,209
+3% +$20.4K
STM icon
2332
STMicroelectronics
STM
$49.9B
$797K ﹤0.01%
18,443
+1,635
+10% +$73.8K
CGEM icon
2333
Cullinan Oncology
CGEM
$1.14B
$796K ﹤0.01%
46,702
+972
+2% +$15K
CATC
2334
DELISTED
CAMBRIDGE BANCORP
CATC
$796K ﹤0.01%
11,675
+355
+3% +$23.5K
AMNB
2335
DELISTED
American National Bankshares Inc
AMNB
$793K ﹤0.01%
16,594
+520
+3% +$24K
ALC icon
2336
Alcon
ALC
$35.2B
$792K ﹤0.01%
9,507
+5
+0.1% +$401
EVLV icon
2337
Evolv Technologies
EVLV
$1.09B
$791K ﹤0.01%
177,840
+6,329
+4% +$27.3K
PWP icon
2338
Perella Weinberg Partners
PWP
$1.26B
$790K ﹤0.01%
55,889
-64
-0.1% -$804
RUSHB icon
2339
Rush Enterprises Class B
RUSHB
$6.14B
$789K ﹤0.01%
14,798
+230
+2% +$11.4K
LAND
2340
Gladstone Land Corp
LAND
$353M
$788K ﹤0.01%
59,099
-799
-1% -$10.8K
CABA icon
2341
Cabaletta Bio
CABA
$455M
$778K ﹤0.01%
45,606
+1,459
+3% +$31.3K
OIS icon
2342
Oil States International
OIS
$512M
$778K ﹤0.01%
126,273
-108,554
-46% -$648K
GSBC icon
2343
Great Southern Bancorp
GSBC
$877M
$778K ﹤0.01%
14,184
-669
-5% -$35.6K
LXU icon
2344
LSB Industries
LXU
$721M
$773K ﹤0.01%
88,060
+1,799
+2% +$14.2K
BCH icon
2345
Banco de Chile
BCH
$20.8B
$771K ﹤0.01%
34,631
+7,480
+28% +$168K
MLNK
2346
DELISTED
MeridianLink
MLNK
$771K ﹤0.01%
41,232
+1,027
+3% +$20.9K
CHPT icon
2347
ChargePoint
CHPT
$162M
$771K ﹤0.01%
20,282
+1,987
+11% +$77.9K
NVTS icon
2348
Navitas Semiconductor
NVTS
$3.61B
$770K ﹤0.01%
161,414
+4,741
+3% +$27.8K
CLNE icon
2349
Clean Energy Fuels
CLNE
$355M
$766K ﹤0.01%
285,758
+5,357
+2% +$16K
FNA
2350
DELISTED
Paragon 28, Inc.
FNA
$766K ﹤0.01%
62,007
+1,367
+2% +$16.3K

Similar funds

RhumbLine Advisers's Q1 2024 Portfolio in Review

As of Q1 2024, RhumbLine Advisers held 4,372 positions worth $104B, up 9.1% from $95.4B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Trading was light in Q1 2024: portfolio turnover was 3%. RhumbLine Advisers opened 62 new positions and exited 71, leaving the 4,372-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 28% a quarter earlier, followed by Financials and Healthcare.

  • RhumbLine Advisers's largest Q1 2024 buy was Dayforce: 278,394 shares worth $18.4M.
  • RhumbLine Advisers added most to Amazon in Q1 2024, an estimated $35.4M increase.
  • RhumbLine Advisers's biggest Q1 2024 reduction was Procter & Gamble, cutting an estimated $46.7M.
  • RhumbLine Advisers fully exited Splunk Inc in Q1 2024, selling an estimated $32.3M.
  • RhumbLine Advisers's ten largest holdings make up 26% of its $104B portfolio in Q1 2024.
  • RhumbLine Advisers opened 62 new positions and closed 71 in Q1 2024.
  • RhumbLine Advisers's portfolio value rose 9.1% quarter-over-quarter to $104B.

Based on RhumbLine Advisers's 13F filing for Q1 2024, filed 9 May 2024.